key: cord-1039899-n30yt31h
authors: Szoke, Dominika; Caruso, Simone; Aloisio, Elena; Pasqualetti, Sara; Dolci, Alberto; Panteghini, Mauro
title: Serum potassium concentrations in COVID-19
date: 2020-11-22
journal: Clin Chim Acta
DOI: 10.1016/j.cca.2020.11.012
sha: 31dbc83be2895930efba090caafe43640d1b6fec
doc_id: 1039899
cord_uid: n30yt31h

nan

Recent evidence has associated COVID-19 to hypokalemia and other ion imbalances, with potential implications for patient management, and causal mechanisms leading to hypokalemia have been proposed [1] [2] [3] [4] [5] [6] . Quite interestingly, Moreno-Pérez et al. [4] have described hypokalemia as a marker of disease severity and of need for mechanical ventilation in COVID-19 patients.

For further evaluating the frequency of hypokalemia in COVID-19 and its possible association with poor outcomes, i.e., in-hospital death and the need of admission to intensive care unit (ICU), we performed a retrospective, observational study on patients admitted between February and April 2020 to our national reference center for infectious diseases. We retrieved the admission potassium value in 874 COVID-19 and 538 SARS-CoV-2 negative patients. Patients in COVID-19 group were significantly older than controls 12.6%; p=0.005). For 603 COVID-19 patients we were able to retrieve the potassium values of the whole hospitalization period together with clinical outcomes (Table 1) . Ninetythree (15.4%) patients died and 68 (11.3%) patients required admission to ICU. Nonsurvivors were significantly older, and males more frequently died and needed intensive care than females. At admission, 126 (20.9%) patients had hypokalemia and the rate increased to 36.3% if the nadir potassium concentrations were considered. Receiver operating characteristic curve analysis was performed, but the areas under the curve were always ≤0.6, showing a poor accuracy of hypokalemia in predicting the two selected outcomes. At univariate analysis, age was a predictor of death during hospitalization, while hypokalemia, both at admission and nadir, did not. Nadir hypokalemia gave only a borderline significance in predicting ICU admission (p=0.052).

Several laboratory tests have been proposed to identify patients with severe COVID-19 [7] . Among those, hypokalemia has been related to poor prognosis [3, 4] .

Although our data confirmed an elevated prevalence of hypokalemia in COVID-19 patients during their hospitalization, we were unable to specifically relate this dysionemic state to patient death and the need of intensive care.

Declarations of interest: none. a Data are reported as absolute number and percentage for categorical variables and median with interquartile range for quantitative variables. Differences between variables in different categories were assessed by applying chi-squared test (categorical) and Mann-Whitney rank-sum test (quantitative). Hypokalemia was defined as plasma K <3.5 mmol/L; hyperkalemia was defined as plasma K >5.0 mmol/L.

Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease

Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)

Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients

Hypokalemia as a sensitive biomarker of disease severity and invasive mechanical ventilation requirement in COVID-19 pneumonia

Mediterranean patients

Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?

Covid-19 and the digestive system

A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID-19 severity